Devyser secures SEK 8.9M five-year tender and strengthens Italian position
Devyser, a leading provider of advanced genetic testing solutions, has been awarded a tender in...
Thank you for requesting one of our whitepapers.
Noninvasive fetal RHD testing is emerging as a standard of care: insights from a global survey
Alloimmunization against Rhesus D (RhD) is the leading cause of hemolytic disease of the fetus and...
A workflow the team trusts: Several years of routine CFTR testing in a reproductive genetics lab in Germany
For many laboratories, CFTR testing is not an occasional add-on. It is part of a routine,...
.jpg)
Devyser launches the first IVDR compliant NGS assay for thalassemia and sickle cell disease testing
Devyser, today announced the launch of Devyser Thalassemia v2, the first Next-Generation Sequencing...